New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
11:28 EDTMDCOThe Medicines Co. briefing documents mixed, says Jefferies
Jefferies views the briefing documents for The Medicines Co.'s cangrelor as mixed with one reviewer recommending against approval and one for approval. The firm thinks the dose and timing of the loading dose will be a key topic of discussion at the advisory meeting on Wednesday and keeps a Buy rating on The Medicines Co.
News For MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2015
12:02 EDTMDCOThe Medicines Co. receives EC approval for IONSYS
The Medicines Company announced that the European Commission has granted marketing authorization for IONSYS(40 micrograms per dose transdermal system), with active ingredient fentanyl, for the management of acute moderate-to-severe, post-operative pain in adult patients for use in the hospital. IONSYS will be the only needle-free, patient-controlled, pre-programmed iontophoretic transdermal delivery system for use in adult patients requiring opioid analgesia in EU hospital settings. The marketing authorization follows the issuance of a positive opinion in September by the Committee for Medicinal Products for Human Use of the European Medicines Agency and is now valid in the 31 countries of the European Economic Area, which includes all 28 European Union Member States, plus Norway, Iceland and Liechtenstein. A supplemental new drug application for IONSYS was approved by the U.S. FDA in April 2015 with an approved IONSYS Risk Evaluation Mitigation Strategy program. The product is commercially available in the U.S. as of July 2015.
November 13, 2015
14:52 EDTMDCOFederal Circuit overturns District Court decision on Angiomax patents
Subscribe for More Information
13:57 EDTMDCOAppeals court vacates decision invalidating Medicines Co. Angiomax patents
Subscribe for More Information
13:38 EDTMDCOThe Medicines Co. jumps 9% following reports of court decision
Shares of The Medicines Co. jumped after reports surfaced that an appeals court vacated the decision invalidating Angiomax patents.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use